MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines

International Journal of Molecular Sciences

Volumn 15, Issue 11, 2014, Pages 20134-20157

  Wagner, Andrej ^a   Mayr, Christian ^a   Bach, Doris ^a   Illig, Romana ^a   Plaetzer, Kristjan ^b   Berr, Frieder ^a   Pichler, Martin ^c,d   Neureiter, Daniel ^a   Kiesslich, Tobias ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF SALZBURG   (Austria)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bile duct cancer; Cytotoxicity; MicroRNAs; Photodynamic therapy; Sensitivity

Indexed keywords

CYCLIN D1; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 8; GLUTATHIONE; KI 67 ANTIGEN; MESO TETRAHYDROXYPHENYLCHLORINE; MICRORNA; MICRORNA 135A; MICRORNA 106B; MICRORNA 135B; MICRORNA 141; MICRORNA 200; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 203; MICRORNA 20A; MICRORNA 25; MICRORNA 326; MICRORNA 330; MICRORNA 429; MICRORNA 516 3P; MICRORNA 590 5B; MICRORNA 664; MICRORNA 93; PHOTOFRIN; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIMENTIN; MESOPORPHYRIN; TEMOPORFIN; TUMOR MARKER;

ARTICLE; BILIARY TRACT CANCER; BIOINFORMATICS; CELL VIABILITY; COMPUTER MODEL; CONTROLLED STUDY; CYTOTOXICITY; DNA MICROARRAY; FLUOROMETRY; GENE EXPRESSION; GENE ONTOLOGY; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MRNA EXPRESSION ASSAY; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; REAL TIME POLYMERASE CHAIN REACTION; BILIARY TRACT NEOPLASMS; BIOLOGY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; COMPUTER SIMULATION; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHOTOCHEMOTHERAPY; TREATMENT OUTCOME; TUMOR CELL LINE;

BILIARY TRACT NEOPLASMS; BIOMARKERS, TUMOR; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ONTOLOGY; GLUTATHIONE; HUMANS; MESOPORPHYRINS; MICRORNAS; PHOTOCHEMOTHERAPY; TREATMENT OUTCOME;

EID: 84908577176     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151120134     Document Type: Article

References (109)

1. Jarnagin, W.R.; Shoup, M. Surgical management of cholangiocarcinoma. Semin Liver Dis. 2004, 24, 189-199.
2. Lazaridis, K.N.; Gores, G.J. Cholangiocarcinoma. Gastroenterology 2005, 128, 1655-1667.
3. Neuhaus, P.; Jonas, S.; Bechstein, W.O.; Lohmann, R.; Radke, C.; Kling, N.; Wex, C.; Lobeck, H.; Hintze, R. Extended resections for hilar cholangiocarcinoma. Ann. Surg. 1999, 230, 808-818.
4. Berr, F. Photodynamic therapy for cholangiocarcinoma. Semin. Liver Dis. 2004, 24, 177-187.
5. Ortner, M.E.; Caca, K.; Berr, F.; Liebetruth, J.; Mansmann, U.; Huster, D.; Voderholzer, W.; Schachschal, G.; Mossner, J.; Lochs, H. Successful photodynamic therapy for nonresectable cholangiocarcinoma: A randomized prospective study. Gastroenterology 2003, 125, 1355-1363.
6. Witzigmann, H.; Berr, F.; Ringel, U.; Caca, K.; Uhlmann, D.; Schoppmeyer, K.; Tannapfel, A.; Wittekind, C.; Mossner, J.; Hauss, J.; et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: Palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann. Surg. 2006, 244, 230-239.
7. Gao, F.; Bai, Y.; Ma, S.R.; Liu, F.; Li, Z.S. Systematic review: Photodynamic therapy for unresectable cholangiocarcinoma. J. Hepatobiliary Pancreat Sci. 2010, 17, 125-131.
8. Kiesslich, T.; Wolkersdorfer, G.; Neureiter, D.; Salmhofer, H.; Berr, F. Photodynamic therapy for non-resectable perihilar cholangiocarcinoma. Photochem. Photobiol. Sci. 2009, 8, 23-30.
9. Agostinis, P.; Berg, K.; Cengel, K.A.; Foster, T.H.; Girotti, A.W.; Gollnick, S.O.; Hahn, S.M.; Hamblin, M.R.; Juzeniene, A.; Kessel, D.; et al. Photodynamic therapy of cancer: An update. CA Cancer J. Clin. 2011, 61, 250-281.
10. Brown, S.B.; Brown, E.A.; Walker, I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 2004, 5, 497-508.
11. Plaetzer, K.; Kiesslich, T.; Oberdanner, C.B.; Krammer, B. Apoptosis following photodynamic tumor therapy: Induction, mechanisms and detection. Curr. Pharm. Des. 2005, 11, 1151-1165.
12. Kiesslich, T.; Berlanda, J.; Plaetzer, K.; Krammer, B.; Berr, F. Comparative characterization of the efficiency and cellular pharmacokinetics of foscan- and foslip-based photodynamic treatment in human biliary tract cancer cell lines. Photochem. Photobiol. Sci. 2007, 6, 619-627.
13. Kiesslich, T.; Neureiter, D.; Alinger, B.; Jansky, G.L.; Berlanda, J.; Mkrtchyan, V.; Ocker, M.; Plaetzer, K.; Berr, F. Uptake and phototoxicity of meso-tetrahydroxyphenyl chlorine are highly variable in human biliary tract cancer cell lines and correlate with markers of differentiation and proliferation. Photochem. Photobiol. Sci. 2010, 9, 734-743.
14. Voorhoeve, P.M. Micrornas: Oncogenes, tumor suppressors or master regulators of cancer heterogeneity? Biochim. Biophys. Acta 2010, 1805, 72-86.
15. Al-Ali, B.M.; Ress, A.L.; Gerger, A.; Pichler, M. Micrornas in renal cell carcinoma: Implications for pathogenesis, diagnosis, prognosis and therapy. Anticancer Res. 2012, 32, 3727-3732.
16. Schwarzenbacher, D.; Balic, M.; Pichler, M. The role of micrornas in breast cancer stem cells. Int. J. Mol. Sci. 2013, 14, 14712-14723.
17. Lu, J.; Getz, G.; Miska, E.A.; Alvarez-Saavedra, E.; Lamb, J.; Peck, D.; Sweet-Cordero, A.; Ebert, B.L.; Mak, R.H.; Ferrando, A.A.; et al. Microrna expression profiles classify human cancers. Nature 2005, 435, 834-838.
18. De Groen, P.C.; Gores, G.J.; LaRusso, N.F.; Gunderson, L.L.; Nagorney, D.M. Biliary tract cancers. N. Engl. J. Med. 1999, 341, 1368-1378.
19. Dweep, H.; Sticht, C.; Pandey, P.; Gretz, N. Mirwalk-Database: Prediction of possible mirna binding sites by "walking" the genes of three genomes. J. Biomed. Inform. 2011, 44, 839-847.
20. O'Brien, J.; Wilson, I.; Orton, T.; Pognan, F. Investigation of the alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 2000, 267, 5421-5426.
21. Pieslinger, A.; Plaetzer, K.; Oberdanner, C.B.; Berlanda, J.; Mair, H.; Krammer, B.; Kiesslich, T. Characterization of a simple and homogeneous irradiation device based on light-emitting diodes: A possible low-cost supplement to conventional light sources for photodynamic treatment. Med. Laser Appl. 2006, 21, 277-283.
22. Wang, K.K.; Mitra, S.; Foster, T.H. Photodynamic dose does not correlate with long-term tumor response to mTHPC-PDT performed at several drug-light intervals. Med. Phys. 2008, 35, 3518-3526.
23. Wang, X.; el Naqa, I.M. Prediction of both conserved and nonconserved microrna targets in animals. Bioinformatics 2008, 24, 325-332.
24. Kiesslich, T.; Alinger, B.; Wolkersdorfer, G.W.; Ocker, M.; Neureiter, D.; Berr, F. Active Wnt signalling is associated with low differentiation and high proliferation in human biliary tract cancer in vitro and in vivo and is sensitive to pharmacological inhibition. Int. J. Oncol. 2010, 36, 49-58.
25. Anton, R.; Chatterjee, S.S.; Simundza, J.; Cowin, P.; Dasgupta, R. A systematic screen for micro-rnas regulating the canonical wnt pathway. PLoS One 2011, 6, e26257.
26. Zhang, R.; Wang, W.; Li, F.; Zhang, H.; Liu, J. Microrna-106b~25 expressions in tumor tissues and plasma of patients with gastric cancers. Med. Oncol. 2014, 31, doi:10.1007/s12032-014-0243-x.
27. Espinosa-Parrilla, Y.; Munoz, X.; Bonet, C.; Garcia, N.; Vencesla, A.; Yiannakouris, N.; Naccarati, A.; Sieri, S.; Panico, S.; Huerta, J.M.; et al. Genetic association of gastric cancer with mirna clusters including the cancer-related genes mir29, mir25, mir93 and mir106: Results from the epic-eurgast study. Int. J. Cancer 2014, 135, 2065-2076.
28. Singh, B.; Ronghe, A.M.; Chatterjee, A.; Bhat, N.K.; Bhat, H.K. MicroRNA-93 regulates Nrf2 expression and is associated with breast carcinogenesis. Carcinogenesis 2013, 34, 1165-1172.
29. Li, N.; Muthusamy, S.; Liang, R.; Sarojini, H.; Wang, E. Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1. Mech. Ageing Dev. 2011, 132, 75-85.
30. Fu, X.; Tian, J.; Zhang, L.; Chen, Y.; Hao, Q. Involvement of microrna-93, a new regulator of pten/akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells. FEBS Lett. 2012, 586, 1279-1286.
31. Eades, G.; Yang, M.; Yao, Y.; Zhang, Y.; Zhou, Q. miR-200a regulates Nrf2 activation by targeting keap1 mRNA in breast cancer cells. J. Biol. Chem. 2011, 286, 40725-40733.
32. Saydam, O.; Shen, Y.; Wurdinger, T.; Senol, O.; Boke, E.; James, M.F.; Tannous, B.A.; Stemmer-Rachamimov, A.O.; Yi, M.; Stephens, R.M.; et al. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing e-cadherin and activating the wnt/beta-catenin signaling pathway. Mol. Cell Biol. 2009, 29, 5923-5940.
33. Korpal, M.; Lee, E.S.; Hu, G.; Kang, Y. The mir-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of e-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 2008, 283, 14910-14914.
34. Mongroo, P.S.; Rustgi, A.K. The role of the mir-200 family in epithelial-mesenchymal transition. Cancer Biol. Ther. 2010, 10, 219-222.
35. Park, S.M.; Gaur, A.B.; Lengyel, E.; Peter, M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the e-cadherin repressors zeb1 and zeb2. Genes Dev. 2008, 22, 894-907.
36. Liu, Q.; Li, R.T.; Qian, H.Q.; Wei, J.; Xie, L.; Shen, J.; Yang, M.; Qian, X.P.; Yu, L.X.; Jiang, X.Q.; et al. Targeted delivery of miR-200c/doc to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles. Biomaterials 2013, 34, 7191-7203.
37. Lo, W.L.; Yu, C.C.; Chiou, G.Y.; Chen, Y.W.; Huang, P.I.; Chien, C.S.; Tseng, L.M.; Chu, P.Y.; Lu, K.H.; Chang, K.W.; et al. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J. Pathol. 2011, 223, 482-495.
38. Lin, C.H.; Hung, P.H.; Chen, Y.J. Cd44 is associated with the aggressive phenotype of nasopharyngeal carcinoma through redox regulation. Int. J. Mol. Sci. 2013, 14, 13266-13281.
39. + ovarian cancer stem cells by regulating epithelial-mesenchymal transition. J. Ovarian Res. 2013, 6, doi:10.1186/1757-2215-6-50.
40. Ju, S.Y.; Chiou, S.H.; Su, Y. Maintenance of the stemness in CD44 HCT-15 and hct-116 human colon cancer cells requires miR-203 suppression. Stem Cell Res. 2013, 12, 86-100.
41. Bach, D.; Fuereder, J.; Karbiener, M.; Scheideler, M.; Ress, A.L.; Neureiter, D.; Kemmerling, R.; Dietze, O.; Wiederstein, M.; Berr, F.; et al. Comprehensive analysis of alterations in the mirnome in response to photodynamic treatment. J. Photochem. Photobiol. B 2013, 120, 74-81.
42. Kushibiki, T. Photodynamic therapy induces microRNA-210 and -296 expression in hela cells. J. Biophotonics 2010, 3, 368-372.
43. Beissbarth, T.; Speed, T.P. Gostat: Find statistically overrepresented gene ontologies within a group of genes. Bioinformatics 2004, 20, 1464-1465.
44. Dai, Y.; Zhou, X. Computational methods for the identification of microrna targets. Open Access Bioinform. 2010, 2, 29-39.
45. Huang da, W.; Sherman, B.T.; Lempicki, R.A. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37, 1-13.
46. Huang da, W.; Sherman, B.T.; Lempicki, R.A. Systematic and integrative analysis of large gene lists using david bioinformatics resources. Nat. Protoc. 2009, 4, 44-57.
47. Circu, M.L.; Aw, T.Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic. Biol. Med. 2010, 48, 749-762.
48. Kushibiki, T.; Hirasawa, T.; Okawa, S.; Ishihara, M. Responses of cancer cells induced by photodynamic therapy. J. Healthc. Eng. 2013, 4, 87-108.
49. Trachootham, D.; Lu, W.; Ogasawara, M.A.; Nilsa, R.D.; Huang, P. Redox regulation of cell survival. Antioxid. Redox Signal. 2008, 10, 1343-1374.
50. Budanov, A.V.; Sablina, A.A.; Feinstein, E.; Koonin, E.V.; Chumakov, P.M. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial ahpd. Science 2004, 304, 596-600.
51. Chang, T.S.; Cho, C.S.; Park, S.; Yu, S.; Kang, S.W.; Rhee, S.G. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J. Biol. Chem. 2004, 279, 41975-41984.
52. Ferrario, A.; von Tiehl, K.F.; Rucker, N.; Schwarz, M.A.; Gill, P.S.; Gomer, C.J. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res. 2000, 60, 4066-4069.
53. Koukourakis, M.I.; Giatromanolaki, A.; Skarlatos, J.; Corti, L.; Blandamura, S.; Piazza, M.; Gatter, K.C.; Harris, A.L. Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res. 2001, 61, 1830-1832.
54. Majmundar, A.J.; Wong, W.J.; Simon, M.C. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 2010, 40, 294-309.
55. Mitra, S.; Cassar, S.E.; Niles, D.J.; Puskas, J.A.; Frelinger, J.G.; Foster, T.H. Photodynamic therapy mediates the oxygen-independent activation of hypoxia-inducible factor 1α. Mol. Cancer Ther. 2006, 5, 3268-3274.
56. Kim, W.; Kim, J.E. Sirt7 an emerging sirtuin: Deciphering newer roles. J. Physiol. Pharmacol. 2013, 64, 531-534.
57. Ferrario, A.; Gomer, C.J. Avastin enhances photodynamic therapy treatment of kaposi's sarcoma in a mouse tumor model. J. Environ. Pathol. Toxicol. Oncol. 2006, 25, 251-259.
58. Meng, S.; Cao, J.T.; Zhang, B.; Zhou, Q.; Shen, C.X.; Wang, C.Q. Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene spred-1. J. Mol. Cell. Cardiol. 2012, 53, 64-72.
59. Ou, J.; Fontana, J.T.; Ou, Z.; Jones, D.W.; Ackerman, A.W.; Oldham, K.T.; Yu, J.; Sessa, W.C.; Pritchard, K.A., Jr. Heat shock protein 90 and tyrosine kinase regulate eNOS NO* generation but not NO* bioactivity. Am. J. Physiol. Heart Circ. Physiol. 2004, 286, H561-H569.
60. Roviezzo, F.; Cuzzocrea, S.; di Lorenzo, A.; Brancaleone, V.; Mazzon, E.; di Paola, R.; Bucci, M.; Cirino, G. Protective role of PI3-kinase-Akt-eNOS signalling pathway in intestinal injury associated with splanchnic artery occlusion shock. Br. J. Pharmacol. 2007, 151, 377-383.
61. Sessa, W.C. eNOS at a glance. J. Cell Sci. 2004, 117, 2427-2429.
62. Granville, D.J.; Carthy, C.M.; Jiang, H.; Levy, J.G.; McManus, B.M.; Matroule, J.Y.; Piette, J.; Hunt, D.W. Nuclear factor-κB activation by the photochemotherapeutic agent verteporfin. Blood 2000, 95, 256-262.
63. Oleinick, N.L.; Morris, R.L.; Belichenko, I. The role of apoptosis in response to photodynamic therapy: What, where, why, and how. Photochem. Photobiol. Sci. 2002, 1, 1-21.
64. Yuan, Z.Q.; Feldman, R.I.; Sun, M.; Olashaw, N.E.; Coppola, D.; Sussman, G.E.; Shelley, S.A.; Nicosia, S.V.; Cheng, J.Q. Inhibition of jnk by cellular stress- and tumor necrosis factor α-induced Akt2 through activation of the Nfκb pathway in human epithelial cells. J. Biol. Chem. 2002, 277, 29973-29982.
65. Zhuang, S.; Kochevar, I.E. Singlet oxygen-induced activation of Akt/protein kinase b is independent of growth factor receptors. Photochem. Photobiol. 2003, 78, 361-371.
66. Kessel, D. Promotion of PDT efficacy by a bcl-2 antagonist. Photochem. Photobiol. 2008, 84, 809-814.
67. Koukourakis, M.I.; Corti, L.; Skarlatos, J.; Giatromanolaki, A.; Krammer, B.; Blandamura, S.; Piazza, M.; Verwanger, T.; Schnitzhofer, G.; Kostandelos, J.; et al. Clinical and experimental evidence of bcl-2 involvement in the response to photodynamic therapy. Anticancer Res. 2001, 21, 663-668.
68. Srivastava, M.; Ahmad, N.; Gupta, S.; Mukhtar, H. Involvement of bcl-2 and bax in photodynamic therapy-mediated apoptosis. Antisense bcl-2 oligonucleotide sensitizes rif 1 cells to photodynamic therapy apoptosis. J. Biol. Chem. 2001, 276, 15481-15488.
69. Fu, Y.; Zhang, Y.; Wang, Z.; Wang, L.; Wei, X.; Zhang, B.; Wen, Z.; Fang, H.; Pang, Q.; Yi, F. Regulation of nadph oxidase activity is associated with mirna-25-mediated nox4 expression in experimental diabetic nephropathy. Am. J. Nephrol. 2010, 32, 581-589.
70. Tian, X.Y.; Yung, L.H.; Wong, W.T.; Liu, J.; Leung, F.P.; Liu, L.; Chen, Y.; Kong, S.K.; Kwan, K.M.; Ng, S.M.; et al. Bone morphogenic protein-4 induces endothelial cell apoptosis through oxidative stress-dependent p38mapk and jnk pathway. J. Mol. Cell. Cardiol. 2012, 52, 237-244.
71. Zhu, P.; Tong, B.M.; Wang, R.; Chen, J.P.; Foo, S.; Chong, H.C.; Wang, X.L.; Ang, G.Y.; Chiba, S.; Tan, N.S. Nox4-dependent ROS modulation by amino endoperoxides to induce apoptosis in cancer cells. Cell Death Dis. 2013, 4, doi:10.1038/cddis.2013.68.
72. Weyergang, A.; Berg, K.; Kaalhus, O.; Peng, Q.; Selbo, P.K. Photodynamic therapy targets the mtor signaling network in vitro and in vivo. Mol. Pharm. 2009, 6, 255-264.
73. Curnow, A.; McIlroy, B.W.; Postle-Hacon, M.J.; Porter, J.B.; MacRobert, A.J.; Bown, S.G. Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agents. Br. J. Cancer 1998, 78, 1278-1282.
74. Ma, N.; Xiang, Y.; Zhang, Y.; Zhao, X.; Zhou, L.; Gao, X. The balance mediated by mirnas and the heme oxygenase 1 feedback loop contributes to biological effects. J. Cell. Biochem. 2013, 114, 2637-2642.
75. Miyake, M.; Ishii, M.; Kawashima, K.; Kodama, T.; Sugano, K.; Fujimoto, K.; Hirao, Y. Sirna-mediated knockdown of the heme synthesis and degradation pathways: Modulation of treatment effect of 5-aminolevulinic acid-based photodynamic therapy in urothelial cancer cell lines. Photochem. Photobiol. 2009, 85, 1020-1027.
76. Nowis, D.; Legat, M.; Grzela, T.; Niderla, J.; Wilczek, E.; Wilczynski, G.M.; Glodkowska, E.; Mrowka, P.; Issat, T.; Dulak, J.; et al. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. Oncogene 2006, 25, 3365-3374.
77. Shan, Y.; Lambrecht, R.W.; Ghaziani, T.; Donohue, S.E.; Bonkovsky, H.L. Role of bach-1 in regulation of heme oxygenase-1 in human liver cells: Insights from studies with small interfering rnas. J. Biol. Chem. 2004, 279, 51769-51774.
78. Goyal, P.; Weissmann, N.; Grimminger, F.; Hegel, C.; Bader, L.; Rose, F.; Fink, L.; Ghofrani, H.A.; Schermuly, R.T.; Schmidt, H.H.; et al. Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species. Free Radic. Biol. Med. 2004, 36, 1279-1288.
79. Cao, L.Q.; Xue, P.; Lu, H.W.; Zheng, Q.; Wen, Z.L.; Shao, Z.J. Hematoporphyrin derivative-mediated photodynamic therapy inhibits tumor growth in human cholangiocarcinoma in vitro and in vivo. Hepatol. Res. 2009, 39, 1190-1197.
80. Kushibiki, T.; Hirasawa, T.; Okawa, S.; Ishihara, M. Regulation of miRNA Expression by Low-Level Laser Therapy (LLLT) and Photodynamic Therapy (PDT). Int. J. Mol. Sci. 2013, 14, 13542-13558.
81. Wang, J.B.; Liu, L.X.; Pan, S.H.; Wang, C.Y.; Fu, Q.F. Therapeutic effect of photodynamic therapy using hematoporphyrin monomethyl ether (hmme) on human cholangiocarcinoma cell line qbc939. Neoplasma 2010, 57, 79-85.
82. Wei, J.; Zhang, Y.; Luo, Y.; Wang, Z.; Bi, S.; Song, D.; Dai, Y.; Wang, T.; Qiu, L.; Wen, L.; et al. Aldose reductase regulates miR-200a-3p/141-3p to coordinate keap1-nrf2, TGFβ1/2, and zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice. Free Radic. Biol. Med. 2013, 67C, 91-102.
83. Bhowmick, R.; Girotti, A.W. Pro-survival and pro-growth effects of stress-induced nitric oxide in a prostate cancer photodynamic therapy model. Cancer Lett. 2014, 343, 115-122.
84. Henderson, B.W.; Sitnik-Busch, T.M.; Vaughan, L.A. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent. Photochem. Photobiol. 1999, 70, 64-71.
85. Ferrario, A.; Rucker, N.; Wong, S.; Luna, M.; Gomer, C.J. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response. Cancer Res. 2007, 67, 4989-4995.
86. Korbelik, M.; Sun, J.; Cecic, I. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: Relevance for tumor response. Cancer Res. 2005, 65, 1018-1026.
87. Nonaka, M.; Ikeda, H.; Inokuchi, T. Inhibitory effect of heat shock protein 70 on apoptosis induced by photodynamic therapy in vitro. Photochem. Photobiol. 2004, 79, 94-98.
88. Kleban, J.; Mikes, J.; Horvath, V.; Sackova, V.; Hofmanova, J.; Kozubik, A.; Fedorocko, P. Mechanisms involved in the cell cycle and apoptosis of HT-29 cells pre-treated with mk-886 prior to photodynamic therapy with hypericin. J. Photochem. Photobiol. B 2008, 93, 108-118.
89. Gregory, P.A.; Bert, A.G.; Paterson, E.L.; Barry, S.C.; Tsykin, A.; Farshid, G.; Vadas, M.A.; Khew-Goodall, Y.; Goodall, G.J. The miR-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting zeb1 and sip1. Nat. Cell Biol. 2008, 10, 593-601.
90. Pichler, M.; Ress, A.L.; Winter, E.; Stiegelbauer, V.; Karbiener, M.; Schwarzenbacher, D.; Scheideler, M.; Ivan, C.; Jahn, S.W.; Kiesslich, T.; et al. miR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients. Br. J. Cancer 2014, 110, 1614-1621.
91. Ekshyyan, O.; Aw, T.Y. Decreased susceptibility of differentiated pc12 cells to oxidative challenge: Relationship to cellular redox and expression of apoptotic protease activator factor-1. Cell Death Differ. 2005, 12, 1066-1077.
92. Ishimoto, T.; Sugihara, H.; Watanabe, M.; Sawayama, H.; Iwatsuki, M.; Baba, Y.; Okabe, H.; Hidaka, K.; Yokoyama, N.; Miyake, K.; et al. Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation. Carcinogenesis 2013, 35, 1003-1011.
93. Gammon, L.; Biddle, A.; Heywood, H.K.; Johannessen, A.C.; Mackenzie, I.C. Sub-sets of cancer stem cells differ intrinsically in their patterns of oxygen metabolism. PLoS One 2013, 8, e62493.
94. Giannoni, E.; Buricchi, F.; Grimaldi, G.; Parri, M.; Cialdai, F.; Taddei, M.L.; Raugei, G.; Ramponi, G.; Chiarugi, P. Redox regulation of anoikis: Reactive oxygen species as essential mediators of cell survival. Cell Death Differ. 2008, 15, 867-878.
95. Kumar, S.; Park, S.H.; Cieply, B.; Schupp, J.; Killiam, E.; Zhang, F.; Rimm, D.L.; Frisch, S.M. A pathway for the control of anoikis sensitivity by e-cadherin and epithelial-to-mesenchymal transition. Mol. Cell. Biol. 2011, 31, 4036-4051.
96. 2 ratio and confers anoikis resistance to tumors. Cancer Cell 2011, 19, 401-415.
97. Pervaiz, S.; Clement, M.V. Superoxide anion: Oncogenic reactive oxygen species? Int. J. Biochem. Cell Biol. 2007, 39, 1297-1304.
98. Kemmerling, R.; Alinger, B.; Dietze, O.; Bosmuller, H.C.; Ocker, M.; Wolkersdorfer, G.W.; Berr, F.; Neureiter, D.; Kiesslich, T. Association of stem cell marker expression pattern and survival in human biliary tract cancer. Int. J. Oncol. 2012, 41, 511-522.
99. Berlanda, J.; Kiesslich, T.; Engelhardt, V.; Krammer, B.; Plaetzer, K. Comparative in vitro study on the characteristics of different photosensitizers employed in PDT. J. Photochem. Photobiol. B 2010, 100, 173-180.
100. Dysart, J.S.; Patterson, M.S. Characterization of photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro. Phys. Med. Biol. 2005, 50, 2597-2616.
101. Moan, J.; Rimington, C.; Malik, Z. Photoinduced degradation and modification of photofrin II in cells in vitro. Photochem. Photobiol. 1988, 47, 363-367.
102. Nichols, M.G.; Foster, T.H. Oxygen diffusion and reaction kinetics in the photodynamic therapy of multicell tumour spheroids. Phys. Med. Biol. 1994, 39, 2161-2181.
103. Wang, X. Mirdb: A microRNA target prediction and functional annotation database with a wiki interface. RNA 2008, 14, 1012-1017.
104. Jiang, F.; Robin, A.M.; Katakowski, M.; Tong, L.; Espiritu, M.; Singh, G.; Chopp, M. Photodynamic therapy with photofrin in combination with buthionine sulfoximine (BSO) of human glioma in the nude rat. Lasers Med. Sci. 2003, 18, 128-133.
105. Kane, L.P.; Mollenauer, M.N.; Xu, Z.; Turck, C.W.; Weiss, A. Akt-dependent phosphorylation specifically regulates cot induction of NF-κB-dependent transcription. Mol. Cell. Biol. 2002, 22, 5962-5974.
106. Luna, M.C.; Wong, S.; Gomer, C.J. Photodynamic therapy mediated induction of early response genes. Cancer Res. 1994, 54, 1374-1380.
107. Xia, Y.; Wang, J.; Liu, T.J.; Yung, W.K.; Hunter, T.; Lu, Z. c-Jun downregulation by HDAC3-dependent transcriptional repression promotes osmotic stress-induced cell apoptosis. Mol. Cell 2007, 25, 219-232.
108. Long, J.; Wang, Y.; Wang, W.; Chang, B.H.; Danesh, F.R. Identification of microrna-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J. Biol. Chem. 2010, 285, 23457-23465.
109. Xu, Y.C.; Wu, R.F.; Gu, Y.; Yang, Y.S.; Yang, M.C.; Nwariaku, F.E.; Terada, L.S. Involvement of traf4 in oxidative activation of c-Jun N-terminal kinase. J. Biol. Chem. 2002, 277, 28051-28057.